These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32545870)

  • 1. Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction.
    Kuo HC
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32545870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and potential urological applications of botulinum toxin A.
    Jiang YH; Liao CH; Kuo HC
    Nat Rev Urol; 2015 Sep; 12(9):519-33. PubMed ID: 26260879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin in urology: a review of clinical potential in the treatment of urologic and sexual conditions.
    Chung E
    Expert Opin Biol Ther; 2015 Jan; 15(1):95-102. PubMed ID: 25347039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin injection for lower urinary tract dysfunction.
    Kuo YC; Kuo HC
    Int J Urol; 2013 Jan; 20(1):40-55. PubMed ID: 22571329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature.
    Moore DC; Cohn JA; Dmochowski RR
    Toxins (Basel); 2016 Mar; 8(4):88. PubMed ID: 27023601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of Action of Botulinum Toxin A in Treatment of Functional Urological Disorders.
    Lin YH; Chiang BJ; Liao CH
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32085522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA).
    Mangera A; Andersson KE; Apostolidis A; Chapple C; Dasgupta P; Giannantoni A; Gravas S; Madersbacher S
    Eur Urol; 2011 Oct; 60(4):784-95. PubMed ID: 21782318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.
    Jhang JF; Jiang YH; Kuo HC
    Int J Urol; 2014 Apr; 21 Suppl 1():49-55. PubMed ID: 24807497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of botulinum toxin for the treatment of urologic pain.
    Russell A; Kavia R; Dasgupta P; Sahai A
    Curr Opin Urol; 2013 Nov; 23(6):570-8. PubMed ID: 24047648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action.
    Jhang JF; Kuo HC
    Toxins (Basel); 2016 Apr; 8(4):120. PubMed ID: 27110822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of botulinum toxin injection for neurogenic detrusor overactivity: Switch of toxin versus second injection of the same toxin.
    Peyronnet B; Castel-Lacanal E; Manunta A; Roumiguié M; Marque P; Rischmann P; Gamé X
    Int J Urol; 2015 Dec; 22(12):1160-5. PubMed ID: 26391575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A for the treatment of lower urinary tract disorders.
    Yokoyama T; Chancellor MB; Oguma K; Yamamoto Y; Suzuki T; Kumon H; Nagai A
    Int J Urol; 2012 Mar; 19(3):202-15. PubMed ID: 22220916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014.
    Apostolidis A; Rahnama'i MS; Fry C; Dmochowski R; Sahai A
    Neurourol Urodyn; 2016 Feb; 35(2):293-8. PubMed ID: 26872570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis.
    Chiu B; Tai HC; Chung SD; Birder LA
    Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradetrusor injection of botulinum toxin A and sacral neuromodulation for neurogenic detrusor overactivity.
    Joussain C; Phé V; Even A; Chartier-Kastler E; Denys P
    Eur J Phys Rehabil Med; 2017 Dec; 53(6):991-997. PubMed ID: 29072045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection.
    Jhang JF; Kuo HC
    Toxins (Basel); 2015 Jun; 7(6):2232-50. PubMed ID: 26094697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin in urology. An inventory].
    Schulte-Baukloh H; Knispel HH
    Urologe A; 2004 Aug; 43(8):963-75. PubMed ID: 15278202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of botulinum toxin in neurourology.
    Schurch B
    Drugs Today (Barc); 2004 Mar; 40(3):205-12. PubMed ID: 15148529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity.
    Peyronnet B; Roumiguié M; Castel-Lacanal E; Guillotreau J; Malavaud B; Marque P; Rischmann P; Gamé X
    Neurourol Urodyn; 2016 Feb; 35(2):267-70. PubMed ID: 25524826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
    Leitner L; Guggenbühl-Roy S; Knüpfer SC; Walter M; Schneider MP; Tornic J; Sammer U; Mehnert U; Kessler TM
    Eur Urol; 2016 Sep; 70(3):522-8. PubMed ID: 27106070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.